Tickr
Home Explore Daily Brief Market Watchlists Portfolio
Research
Catalysts Signal Factory Screener Market News Event Calendar Valuation Plot Heat Map Top Investors Industry Trends Options
AI Assistant Notifications Account
Eupraxia Pharmaceuticals Inc. logo

Eupraxia Pharmaceuticals Inc. (EPRX) Stock Ticker

NASDAQ: EPRX · Healthcare · Biotechnology
$8.01-1.84%
USD · as of 2026-09-28 · market cap $268.2M
Open EPRX in TickrDownload for iPhone

EPRX right now

29% of the float is sold short.
From Tickr's live models · 2026-09-29. Not investment advice.

Market factors today

Tickr 500 vs S&P 500+0.49%+1.0% MTD
Momentum L/S+1.35%+15.1% MTD
High-beta momo L/S+1.46%+22.2% MTD
Rate sensitivity L/S+1.91%+6.9% MTD
Oil sensitivity L/S-2.54%-5.3% MTD
Unprofitable tech-1.43%+3.7% MTD

Unlock the full EPRX picture

🔒 Implied move chart & probabilities
🔒 Live options flow
🔒 AI analysis & chat on EPRX
🔒 Catalysts & earnings
🔒 Strategy Lab
🔒 Financials & estimates
Start your 7-day free trial

About Eupraxia Pharmaceuticals Inc.

Eupraxia Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on the development of products to address therapeutic areas with unmet medical need. Its proprietary Diffusphere technology optimizes drug delivery for applications with significant unmet medical need. The company's product portfolio includes EP-104IAR, which is in Phase III clinical trial for the treatment of knee osteoarthritis; EP-104GI that is in Phase II clinical trial for treating eosinophilic esophagitis; and EP-104, which is under preclinical studies for the treatment of gastrointestinal tract, such as eosinophilic esophagitis. The company was formerly known as Plaza Capital Partners Inc. and changed its name to Eupraxia Pharmaceuticals Inc. in May 2012. Eupraxia Pharmaceuticals Inc. was incorporated in 2011 and is headquartered in Victoria, Canada.

EPRX stock facts

Ticker symbolEPRX
ExchangeNASDAQ
SectorHealthcare
IndustryBiotechnology
Market cap$268.2M
CEOJames A. Helliwell
Employees49
HeadquartersVictoria, BC, CA
IPO date2024-04-05
Websitewww.eupraxiapharma.com

What you can see for EPRX on Tickr

Live EPRX price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the EPRX report.

Rankings

Largest Healthcare companiesLargest companies by market cap

FAQ

What is the ticker symbol for Eupraxia Pharmaceuticals Inc.?

The ticker symbol for Eupraxia Pharmaceuticals Inc. is EPRX, listed on the NASDAQ.

What is EPRX?

Eupraxia Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on the development of products to address therapeutic areas with unmet medical need. Its proprietary Diffusphere technology optimizes drug delivery for applications with significant unmet medical need. The company's product portfolio includes EP-104IAR, which is in Phase III clinical trial for the treatment of knee…

HomeExploreMarketLists
All pages